Increased expression and activity of 11β-HSD-1 in diabetic islets and prevention with troglitazone

Biochemical and Biophysical Research Communications

Volumn 313, Issue 3, 2004, Pages 594-599

  Duplomb, Laurence ^a   Lee, Young ^a   Wang, May Yun ^a   Park, Byung H ^a   Takaishi, Kiyosumi ^a,c   Agarwal, Anil K ^a   Unger, Roger H ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c DAIICHI SANKYO CO   (Japan)

Author keywords

11 HSD 1; Cushing's syndrome and obesity; Glucocorticoid; Islets; ZDF (fa fa) rats

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; GLUCOSE; OLEIC ACID; PALMITIC ACID; TROGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE METABOLISM; HYPERGLYCEMIA; HYPERLIPIDEMIA; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT STRAIN; STRAIN DIFFERENCE; WILD TYPE;

EID: 0347064002     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.160     Document Type: Article

References (26)

1. Strain G.W., Zumoff B., Kream J., Strain J.J., Levin J., Fukushima D. Sex difference in the influence of obesity on the 24 hr mean plasma concentration of cortisol. Metabolism. 31:1982;209-212.
2. Filipovsky J., Ducimetiere P., Eschwege E., Richard J.L., Rosselin G., Claude J.R. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J. Hypertens. 14:1996;229-235.
3. Bujalska I.J., Kumar S., Stewart P.M. Does central obesity reflect "Cushing's disease of the omentum"? Lancet. 349:1997;1210-1213.
4. Tomlinson J.W., Bujalska I., Stewart P.M., Cooper M.S. The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis. Endocr. Res. 26:2000;711-722.
5. Livingstone D.E., Kenyon C.J., Walker B.R. Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats. J. Endocrinol. 167:2000;533-539.
6. Draper N., Echwald S.M., Lavery G.G., Walker E.A., Fraser R., Davies E., Sorensen T.I., Astrup A., Adamski J., Hewison M., Connell J.M., Pedersen O., Stewart P.M. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J. Clin. Endocrinol. Metab. 87:2002;4984-4990.
7. Rask E., Walker B.R., Soderberg S., Livingstone D.E., Eliasson M., Johnson O., Andrew R., Olsson T. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J. Clin. Endocrinol. Metab. 87:2002;3330-3336.
8. Paulmyer-Lacroix O., Boullu S., Oliver C., Alessi M.C., Grino M. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J. Clin. Endocrinol. Metab. 87:2002;2701-2705.
9. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science. 294:2001;2166-2170.
10. Masuzaki H., Yamamoto H., Kenyon C.J., Elmquist J.K., Morton N.M., Paterson J.M., Shinyama H., Sharp M.G., Fleming S., Mullins J.J., Seckl J.R., Flier J.S. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J. Clin. Invest. 112:2003;83-90.
11. Ogawa A., Johnson J.H., Ohneda M., McAllister C.T., Inman L., Alam T., Unger R.H. Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes. J. Clin. Invest. 90:1992;497-504.
12. Davani B., Khan A., Hult M., Martensson E., Okret S., Efendic S., Jornvall H., Oppermann U.C. Type 1 11beta -hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets. J. Biol. Chem. 275:2000;34841-34844.
13. Naber S.P., McDonald J.M., Jarett L., McDaniel M.L., Ludvigsen C.W., Lacy P.E. Preliminary characterization of calcium binding in islet-cell plasma membranes. Diabetologia. 19:1980;439-444.
14. Wang M.Y., Koyama K., Shimabukuro M., Newgard C.B., Unger R.H. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Proc. Natl. Acad. Sci. USA. 95:1998;714-718.
15. Agarwal A.K., Monder C. In vitro metabolism of 7 alpha-methyl-19- nortestosterone by rat liver, prostate, and epididymis. Endocrinology. 123:1988;2187-2193.
16. Lee Y., Hirose H., Ohneda M., Johnson J.H., McGarry J.D., Unger R.H. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc. Natl. Acad. Sci. USA. 91:1994;10878-10882.
17. Sreenan S., Sturis J., Pugh W., Burant C.F., Polonsky K.S. Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. Am. J. Physiol. 271:1996;E742-747.
18. Higa M., Zhou Y.T., Ravazzola M., Baetens D., Orci L., Unger R.H. Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc. Natl. Acad. Sci. USA. 96:1999;11513-11518.
19. Shimabukuro M., Zhou Y.T., Lee Y., Unger R.H. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J. Biol. Chem. 273:1998;3547-3550.
20. Shimabukuro M., Higa M., Zhou Y.T., Wang M.Y., Newgard C.B., Unger R.H. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J. Biol. Chem. 273:1998;32487-32490.
21. Berger J., Tanen M., Elbrecht A., Hermanowski-Vosatka A., Moller D.E., Wright S.D., Thieringer R. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. J. Biol. Chem. 276:2001;12629-12635.
22. Phillips M.S., Liu Q., Hammond H.A., Dugan V., Hey P.J., Caskey C.J., Hess J.F. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet. 13:1996;18-19.
23. Iida M., Murakami T., Ishida K., Mizuno A., Kuwajima M., Shima K. Substitution at codon 269 (glutamine. → proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat Biochem. Biophys. Res. Commun. 224:1996;597-604.
24. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
25. Quinkler M., Kosmale B., Bahr V., Oelkers W., Diederich S. Evidence for isoforms of 11 beta-hydroxysteroid dehydrogenase in the liver and kidney of the guinea pig. J. Endocrinol. 153:1997;291-298.
26. Agarwal A.K. Cortisol metabolism and visceral obesity: role of 11β-hydroxysteroid dehydrogenase type 1 enzyme and reduced co-factor NADPH. Endocr. Res. 29:2003;411-418.